Switch to
More onapp

How to use scorecard? Learn more

Vaishali Pharma Ltd

VAISHALI
Health CarePharmaceuticals
SmallcapWith a market cap of ₹150 cr, stock is ranked 2,354
High RiskStock is 4.67x as volatile as Nifty
140.056.35 (-4.34%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹150 cr, stock is ranked 2,354
High RiskStock is 4.67x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
25.62
PB RatioPB Ratio
3.70
Dividend YieldDiv. Yield
Sector PESector PE
51.91
Sector PBSector PB
5.95
Sector Div YldSctr Div Yld
0.56%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Vaishali Pharma Limited is a pharmaceutical company engaged in dealing in pharmaceutical formulations, active pharmaceutical ingredient (APIs), surgical products, veterinary supplements, and herbal and nutraceutical products

Financial TrendFinancial statements 

202020212022202362.2655.5877.6171.890.021.044.036.60
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Investor Presentation 
Announced OnFeb 6, 2024

Vaishali Pharma Limited has informed the Exchange about Investor Presentation | Download

Vaishali Pharma Limited has informed the Exchange about Investor Presentation | Download

Press Release 
Announced OnFeb 6, 2024

Vaishali Pharma Limited has informed the Exchange regarding a press release dated February 06, 2024, titled "Vaishali Pharma s Q3 FY24 marked by a remarkable 37.59% increase in revenue". | Download

Vaishali Pharma Limited has informed the Exchange regarding a press release dated February 06, 2024, titled "Vaishali Pharma s Q3 FY24 marked by a remarkable 37.59% increase in revenue". | Download

See all events